Exasol sees H1 revenue drop on lower non-recurring sales

Exasol reported preliminary H1 2026 revenue of EUR 19.0M, down vs. last year, largely due to a sharp drop in non-recurring hardware and service revenue. ARR was EUR 37.9M at June 30, 2026 (minimal change), and rolling ARR churn improved to 10% from 24% at end-2025, while expansion with existing clients missed expectations amid weaker willingness to invest in on-premises infrastructure. For FY2026, Exasol expects ARR to move within -2% to +2%, revenue to decline in the upper-single-digit range, and EBITDA of EUR 3.0M–EUR 3.5M.

Analysis

The core signal is not the modest ARR stabilization; it is that the business is still unable to convert customer wins into higher-quality revenue. That usually means the installed base is being defended with lower monetization, while the legacy hardware/services mix is shrinking faster than software recurring revenue can offset it. In the near term, that pressures operating leverage and keeps the equity story hostage to small changes in non-recurring spend rather than durable product demand.

Competitively, the data-sovereignty and AI workload angle helps Exasol retain relevance, but it is not enough to widen the moat if enterprise buyers keep delaying infrastructure decisions. The second-order loser is any adjacent partner ecosystem that depends on implementation and on-prem refresh cycles; the winner is the broader cloud/database stack, especially larger vendors with clearer AI attach rates and distribution scale. Over 1-3 months, the market will likely focus on whether customer expansion reaccelerates; over 6-18 months, the key question is whether this becomes a niche compliance vendor or gets squeezed by larger platforms offering similar analytics with better go-to-market economics.

The contrarian point is that improving churn may look like a turning point, but it can also reflect a smaller, more captive base after weaker accounts already exited. If ARR is flat while revenue still declines, the market should assume the recovery path is longer than management framing suggests. For now, this looks more like a hold/avoid than a buy: the upside case needs evidence that new logos are converting into expansion revenue, not just replacing lost contracts. Falsifiers are a clear reacceleration in ARR above the guided range and a visible inflection in expansion bookings within the next two quarters.

Key Decisions for Investors

• No direct long: avoid initiating EXLGF until there is evidence of expansion revenue inflection; the current setup is too low-quality for a rerating.
• If liquid borrow is available, use EXLGF as a relative-value short against a higher-quality enterprise data/software basket (e.g., ORCL or SNOW) on any rally, targeting 1-3 month underperformance if expansion remains weak.
• Set a watch item for the next two reporting periods: if ARR moves above the +2% end of guidance or expansion bookings improve meaningfully, cover any short thesis immediately.
• For portfolio context, treat this as a signal to favor vendors with cloud/AI monetization visibility over on-prem infrastructure-dependent software names; the beneficiaries are the scale platforms, not the niche database vendors.